Hospira (NYSE:HSP) maintained Hold, target lowered to $58 from $62, at Citigroup. The stock closed yesterday at $52.72 on volume of 5,129,500 shares, above the average daily volume of 1,419,468.
In the past 52-weeks, shares of Hospira have traded between a low of $36.58 and a high of $59.75 and are now at $52.72, which is 44.1% above that low price.
Hospira is currently below its 50-day moving average (MA) of $55.08 and should find support at its 200-day MA of $52.21. In the last five trading sessions, the 50-day MA has climbed 0.64% while the 200-day MA has risen 0.59%.
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company's product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.